Journal Articles:

Gullulu O, Ozcelik E, Tuzlakoglu Ozturk M, Karagoz MS, Tazebay UH. A multi-faceted approach to unravel coding and non-coding gene fusions and target chimeric proteins in ataxia. J Biomol Struct Dyn. 2024 Feb 27:1-21. doi: 10.1080/07391102.2024.2321510. Epub ahead of print. PMID: 38411012.

Özçelik E, Kalaycı A, Çelik B, Avcı A, Akyol H, KılıÇ İB, et al. (2022) Doxorubicin induces prolonged DNA
damage signal in cells overexpressing DEK isoform-2. PLoS ONE 17(10): e0275476. https://doi.org/10.1371/journal. pone.0275476

Çalışkaner ZO, Çakar T, Özçelik E, Özdilek A, Kim AS, Doğan Ö, Bosompem A, Grosveld G, Saka B, Kandilci A.DEK protein level is a biomarker of CD138positive normal and malignant plasma cells. PLoS One. 2017 May 30;12(5):e0178025. doi: 10.1371/journal.pone.0178025. eCollection 2017.

Numata M, Yener MD, Ekmekçi SS, Aydın M, Grosveld G, Cardone M, Terranova S, Geltink RK, Özbek U, Özçelik E, Güleç Ç, Anak S,Karaman S, Öztürk G, Akbıyık M, Kandilci A. High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells. Leuk Res. 2015 Aug;39(8):906-12

Conference Proceedings:

A. Avci., E. Özçelik., A. Kandilci, "Investigation of the Effect of DEK3 Isoform on Cell Migration" Gebze Technical University Post Graduate Research Symposium and Publicity Days 2022, 1-2 Jun 2022.

E. Özçelik, A. Kalayci, B. Çelik, A. Avci, H. Akyol, İ. B. Kiliç, T. Çakar, M. Çetin, M. Tuzlakoğlu Öztürk, Z. O. Çalişkaner, A. Kandilci, High level of DEK isoform­2 delays recovery from doxorubicin induced DNA damage, Poster Presentation, The 45th FEBS Virtual Congress, 03-08 July 2021.

A. Kalayci, E. Özçelik & A. KANDİLCİ, "Investigating The Role Of Overexpression Of DEK Isoform-2 In DNA Repair" Poster Presentation, Gebze Technical University Post Graduate Research Symposium and Publicity Days, 10-11 June 2021, 22 - 163.

E. Özçelik, A. Kalayci, B. Çelik, A. Kandilci, Heterodimerization, secretion and expression patterns of DEK isoforms 1 and 2, Poster Presentation, 7th International Congress of the Molecular Biology Association of Turkey 27-29 September 2019 Istanbul/Turkey, 27-29 September 2019, 1300-0152, 43, 5, 1 - 132.

B. Çelik., E. Özçelik., A. Kandilci, "Cloning of DEK3 Isoform" Gebze Technical University Post Graduate Research Symposium and Publicity Days 2019, 17-18 Jun 2019.

E. Özçelik & A. Kandilci, "Cloning of DEK Protein Isoforms to Retroviral Expression Vectors",
Oral Presentation, Gebze Technical University Post Graduate Research Symposium and Publicity Days 2017, 17-18 May 2017.

Z. Onur Çalışkaner*, Emrah Özçelik*, Ayten Kandilci, "Investigation of the Effect of Endogenous DEK Expression Suppression on the Main Biological Properties of Multiple Myeloma Cell Lines "XIV. National Medical Biology and Genetics Congress, Fethiye, Turkey, 27-30 October 2015. *Equal Contribution

• Third Cycle (Doctoral): Gebze Teknik Üniveristesi Fen Bilimleri Enstitüsü Moleküler Biyoloji ve Genetik Bölümü 2015-2023
• Second Cycle (Master's): Gebze Teknik Üniveristesi Fen Bilimleri Enstitüsü Moleküler Biyoloji ve Genetik Bölümü 2013-2015
• First Cycle (Undergraduate): Ankara Üniveristesi Fen Fakültesi Biyoloji Bölümü 2005-2010

Awards

TUSEB (Health Institite of Türkiye) A Group R&D Grant, Researcher, ‘Investigation of the Effect of Artesunate Compound on NCOA4-Mediated Ferritinophagy in HuCCT-1 Cells’, Enforcing Institution: İstinye University, 2024

TUSEB (Health Institite of Türkiye) A Group R&D Grant, Project Manager, ‘Determination of the effect of the newly identified DEK3 isoform on the transcriptional profile of the MCF-7 breast cancer cell line’, Enforcing Institution: Gebze Technical University

TUBITAK (The Scientific And Technological Research Council of Turkey) 1002, Project Manager, ‘Analysis of the Interaction Between DEK Isoforms (isoform 1 and isoform 2) by Co-immunoprecipitation’, Enforcing Institution: Gebze Technical University